HLA DRB1 CWD Resolution, DRB3,4,5 Intermediate Resolution
Use
This test yields a CWD DRB1 result with low to intermediate resolution DRB3,4, and 5. DRB1 antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
Special Instructions
If you have questions, please contact HLA customer service at 800-533-1037 for assistance in selecting the appropriate HLA test for the patient. Indicate in clinical information which antigen(s) is of interest.
Limitations
This test was developed by Labcorp and its performance characteristics were determined internally. It is not cleared or approved by the FDA. Genotyping may include ambiguous results with multiple genotypes, provided alternative genotypes have at least one including a CWD allele.
Methodology
NGS
Biomarkers
LOINC Codes
- 96637-4
- 57298-2
- 59022-4
- 59021-6
- 59020-8
- 49549-9
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed specimen; clotted specimen; wrong specimen container